Current disease phase-Advanced phase-Blast phase (Lymphoid Myeloid) Posts on Medivizor
Navigation Menu

Current disease phase-Advanced phase-Blast phase (Lymphoid Myeloid) Posts on Medivizor

Inotuzumab ozogamicin with bosutinib for relapsed/refractory Philadelphia chromosome-positive ALL or lymphoid blast phase of CML

Inotuzumab ozogamicin with bosutinib for relapsed/refractory Philadelphia chromosome-positive ALL or lymphoid blast phase of CML

Posted by on Jun 27, 2021 in Leukemia | 0 comments

In a nutshell This study aimed to investigate if a combination of inotuzumab ozogamicin (InO; Besponsa) and bosutinib (Bo; Bosulif) was safe and effective in patients with relapsed/refractory (r/r) Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL) or lymphoid blast phase (BP) chronic myeloid leukemia...

Read More

Combining Hyper-CVAD and dasatinib treatment for patients with chronic myeloid leukaemia in lymphoid blastic phase and Philadelphia chromosome-positive acute lymphoblastic leukemia

Combining Hyper-CVAD and dasatinib treatment for patients with chronic myeloid leukaemia in lymphoid blastic phase and Philadelphia chromosome-positive acute lymphoblastic leukemia

Posted by on May 16, 2021 in Leukemia | 0 comments

In a nutshell This study aimed to investigate if the combination of dasatinib and hyperfractionated cyclophosphamide (Cytoxan), vincristine (Oncovin), doxorubicin (Adriamycin), and dexamethasone (Decadron) – hyperCVAD – would be safe and effective for patients with chronic myeloid leukemia (CML) in...

Read More
ABOUT USHOW IT WORKSBLOG NEWS PARTNERS CONTACT US PRIVACY POLICY TERMS OF USE
FROM OUR BLOG
LATEST NEWS
CONNECT WITH US
© 2025 Medivizor